Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Goodwin

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Muscle & Nerve|June 1, 1988
Normal myoblast injections provide genetic treatment for murine dystrophyP K Law, T G Goodwin, M G Wang
Advances in Experimental Medicine and Biology|January 1, 1990
Plausible structural/functional/behavioral/biochemical transformations following myoblast transfer therapyP K Law, T G Goodwin, H J Li, et al.
Journal of Animal Science|November 1, 1992
Influence of model and marker on digesta kinetic estimates for sheepJ A Moore, K R Pond, M H Poore, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Myoblast transfer improves muscle genetics/structure/function and normalizes the behavior and life-span of dystrophic miceP K Law, T G Goodwin, H J Li, et al.
Canadian Journal of Physiology and Pharmacology|January 1, 1991
Vital marker for muscle nuclei in myoblast transferQ W Fang, M Chen, H J Li, et al.
Cell Transplantation|January 1, 1992
Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblastsM Chen, H J Li, Q Fang, et al.
Transplantation Proceedings|December 1, 1994
MHC-I antigens on cultured human myoblastsQ Fang, M Chen, H J Li, et al.
Acta Paediatrica Japonica : Overseas Edition|April 1, 1991
Myoblast transfer therapy for Duchenne muscular dystrophyP K Law, T G Goodwin, Q W Fang, et al.
Cell Transplantation|November 1, 1993
Cell transplantation as an experimental treatment for Duchenne muscular dystrophyP K Law, T G Goodwin, Q Fang, et al.
Cell Transplantation|January 1, 1992
Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boysP K Law, T G Goodwin, Q Fang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Muscle & Nerve|June 1, 1988
Normal myoblast injections provide genetic treatment for murine dystrophyP K Law, T G Goodwin, M G Wang
Advances in Experimental Medicine and Biology|January 1, 1990
Plausible structural/functional/behavioral/biochemical transformations following myoblast transfer therapyP K Law, T G Goodwin, H J Li, et al.
Journal of Animal Science|November 1, 1992
Influence of model and marker on digesta kinetic estimates for sheepJ A Moore, K R Pond, M H Poore, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Myoblast transfer improves muscle genetics/structure/function and normalizes the behavior and life-span of dystrophic miceP K Law, T G Goodwin, H J Li, et al.
Canadian Journal of Physiology and Pharmacology|January 1, 1991
Vital marker for muscle nuclei in myoblast transferQ W Fang, M Chen, H J Li, et al.
Cell Transplantation|January 1, 1992
Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblastsM Chen, H J Li, Q Fang, et al.
Transplantation Proceedings|December 1, 1994
MHC-I antigens on cultured human myoblastsQ Fang, M Chen, H J Li, et al.
Acta Paediatrica Japonica : Overseas Edition|April 1, 1991
Myoblast transfer therapy for Duchenne muscular dystrophyP K Law, T G Goodwin, Q W Fang, et al.
Cell Transplantation|November 1, 1993
Cell transplantation as an experimental treatment for Duchenne muscular dystrophyP K Law, T G Goodwin, Q Fang, et al.
Cell Transplantation|January 1, 1992
Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boysP K Law, T G Goodwin, Q Fang, et al.
Pageof 3